+ Site Statistics
References:
52,654,530
Abstracts:
29,560,856
PMIDs:
28,072,755
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn

+ Translate
+ Recently Requested

Multi-functional magnetic resonance imaging predicts for clinico-pathological response to neoadjuvant chemotherapy in primary breast cancer



Multi-functional magnetic resonance imaging predicts for clinico-pathological response to neoadjuvant chemotherapy in primary breast cancer



Breast Cancer Research & Treatment 82(Supplement 1): S59




(PDF emailed within 1 workday: $29.90)

Accession: 035349227

Download citation: RISBibTeXText


Related references

Early changes in functional dynamic magnetic resonance imaging predict for pathologic response to neoadjuvant chemotherapy in primary breast cancer. Clinical Cancer Research 14(20): 6580-6589, 2008

Performances of breast magnetic resonance imaging in the context of neoadjuvant chemotherapy for breast cancer to predict pathological complete response. Journal of Gynecology Obstetrics and Human Reproduction 46(2): 147-154, 2017

Accuracy of magnetic resonance imaging for predicting pathological complete response of breast cancer after neoadjuvant chemotherapy: association with breast cancer subtype. Springerplus 5: 152, 2016

Magnetic resonance imaging in predicting pathological response of triple negative breast cancer following neoadjuvant chemotherapy. Journal of Clinical Oncology 25(35): 5667-5669, 2007

Multiparametric magnetic resonance imaging for predicting pathological response after the first cycle of neoadjuvant chemotherapy in breast cancer. Investigative Radiology 50(4): 195-204, 2015

Prediction of pathological complete response to neoadjuvant chemotherapy by magnetic resonance imaging in breast cancer patients. Breast 24(2): 159-165, 2015

Inflammatory breast cancer after neoadjuvant chemotherapy: can magnetic resonance imaging precisely diagnose the final pathological response?. Annals of Surgical Oncology 15(12): 3609-3613, 2009

Discrepancies Between Pathological Tumor Responses and Estimations of Complete Response by Magnetic Resonance Imaging After Neoadjuvant Chemotherapy Differ by Breast Cancer Subtype. Clinical Breast Cancer 18(2): 128-134, 2017

Role of magnetic resonance imaging for response evaluation and predictive value of tumor biomarkers in the neoadjuvant chemotherapy for breast cancer:a multi-center prospective study. Zhonghua Yi Xue Za Zhi 94(26): 2018-2021, 2015

Radiologic complete response (rCR) in contrast-enhanced magnetic resonance imaging (CE-MRI) after neoadjuvant chemotherapy for early breast cancer predicts recurrence-free survival but not pathologic complete response (pCR). Breast Cancer Research 21(1): 19, 2019

Magnetic Resonance Imaging Combined With Second-look Ultrasonography in Predicting Pathologic Complete Response After Neoadjuvant Chemotherapy in Primary Breast Cancer Patients. Clinical Breast Cancer 19(1): 71-77, 2018

Nottingham Clinico-Pathological Response Index (NPRI) after neoadjuvant chemotherapy (Neo-ACT) accurately predicts clinical outcome in locally advanced breast cancer. Clinical Cancer Research 21(5): 1052-1062, 2016

Preliminary study of early response to neoadjuvant chemotherapy after the first cycle in breast cancer: comparison of 1H magnetic resonance spectroscopy with diffusion magnetic resonance imaging. Japanese Journal of Radiology 28(2): 101-109, 2010

Magnetic resonance imaging patterns of tumor regression after neoadjuvant chemotherapy in breast cancer patients: correlation with pathological response grading system based on tumor cellularity. Journal of Computer Assisted Tomography 36(2): 200-206, 2012

Magnetic resonance imaging response monitoring of breast cancer during neoadjuvant chemotherapy: relevance of breast cancer subtype. Journal of Clinical Oncology 29(6): 660-666, 2011